More recently, it was demonstrated that monocytic MDSCs in patients with bladder cancer, in contrast to healthy donors, frequently co-express membrane-bound enzyme hyaluronidase 2 (Hyal2). The gene discussed is HYAL2; the disease is urinary bladder cancer.